Congenica vs Onco Access

Congenica vs Onco Access, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Congenica is on 38/100 and Onco Access on 15/100.

Congenica logo
CongenicaGenomic data analysis platform for rare diseases and cancer.
Try Congenica
Onco AccessOncoAccess provides a platform for oncology clinical trial matching and patient access.
Try Onco Access

Where each one leads

Congenica

  • our overall score: 38/100 against 15/100
  • agent readiness: 34/100 against 26/100

Onco Access

Leads on none of the measures we hold for both companies.

At a glance

MeasureCongenicaOnco Access
What it isGenomic data analysis platform for rare diseases and cancer.OncoAccess provides a platform for oncology clinical trial matching and patient access.
CategoryHealthTech, MedTech, Genomics, Drug DiscoveryHealthTech, MedTech, Clinical Trials, Drug Discovery
Sells toBusiness modelB2BB2B
OfferingPlatformPlatform
Founded20132023
HeadquartersCambridge, United KingdomNew York, United States
StatusActiveInactive

Size, funding and growth

MeasureCongenicaOnco Access
Total funding$73.8MNot published
Latest roundNot publishedGrant

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCongenicaOnco Access
StartupHub scoreOur 0-100 rating38/10015/100
Traction39/100Not published
Team70/10030/100
Community14/100Not published
Search visibility3/1005/100
Quality35/100Not published
Agent readinessHow well an AI agent can read and act on the siteF (34/100)F (26/100)
Domain ratingLink authority, 0-10045/100Not published

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCongenicaOnco Access
HostingNot detectedAWS
CDNCloudflareCloudflare
CMSWebflowNot detected
AnalyticsGoogle Tag ManagerNot detected

Congenica vs Onco Access: common questions

Which is better, Congenica or Onco Access?

On our 0-100 score Congenica rates higher (38/100 against 15/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.

How do Congenica and Onco Access compare on the numbers?

Congenica leads on our overall score (38/100 against 15/100), agent readiness (34/100 against 26/100).

Read the full Congenica review and pricing or the Onco Access review and pricing. You can also browse other Congenica alternatives we track.